Walleye Capital Adds $5M in Aurinia Pharmaceuticals Inc. ($AUPH)
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Walleye Capital increased its position in Aurinia Pharmaceuticals Inc. ($AUPH) by 1303.92% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 321,567 shares of Aurinia Pharmaceuticals Inc. after buying 298,662 shares during the quarter. Walleye Capital's holdings in Aurinia Pharmaceuticals Inc. were worth $5.46 million as of its most recent filing.
Aurinia Pharmaceuticals Inc. Stock Up 4.2%
Shares of Aurinia Pharmaceuticals Inc. ($AUPH) traded around $16.97 on Saturday, up 4.2% for the day.
Aurinia Pharmaceuticals Inc. Earnings
Analysts Set New Price Targets
About Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.
Get Aurinia Pharmaceuticals Inc. alerts
New 13F filings, insider trades, and analyst moves on $AUPH, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.